Page last updated: 2024-09-02

rx 821002 and guanylyl imidodiphosphate

rx 821002 has been researched along with guanylyl imidodiphosphate in 5 studies

Compound Research Comparison

Studies
(rx 821002)
Trials
(rx 821002)
Recent Studies (post-2010)
(rx 821002)
Studies
(guanylyl imidodiphosphate)
Trials
(guanylyl imidodiphosphate)
Recent Studies (post-2010) (guanylyl imidodiphosphate)
3170452,356118

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Etgen, AM; Karkanias, GB1
García-Sevilla, JA; Sastre, M1
Bétuing, S; Daviaud, D; Hickson, G; Lafontan, M; Lapalu, S; Peyroulan, D; Saulnier-Blache, JS; Valet, P1
Callado, LF; Meana, JJ1
Pihlavisto, M; Scheinin, M; Sjöholm, B; Wurster, S1

Other Studies

5 other study(ies) available for rx 821002 and guanylyl imidodiphosphate

ArticleYear
A thermodynamic analysis of estrogen regulation of alpha 2-adrenoceptor binding.
    Brain research, 1995, Mar-13, Volume: 674, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Binding Sites; Binding, Competitive; Dioxanes; Estradiol; Female; Guanylyl Imidodiphosphate; Hypothalamus; Idazoxan; Ligands; Ovariectomy; Oxymetazoline; Preoptic Area; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Temperature; Thermodynamics

1995
Alpha 2-adrenoceptor subtypes identified by [3H]RX821002 binding in the human brain: the agonist guanoxabenz does not discriminate different forms of the predominant alpha 2A subtype.
    Journal of neurochemistry, 1994, Volume: 63, Issue:3

    Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Binding, Competitive; Brain; Dioxanes; Edetic Acid; Female; Guanabenz; Guanylyl Imidodiphosphate; Humans; Idazoxan; Imidazoles; Indoles; Isoindoles; Isoquinolines; Male; Piperazines; Receptors, Adrenergic, alpha; Sodium Chloride; Tritium

1994
Functional consequences of constitutively active alpha2A-adrenergic receptor expression in 3T3F442A preadipocytes and adipocytes.
    Biochemical and biophysical research communications, 1997, Jun-27, Volume: 235, Issue:3

    Topics: 3T3 Cells; Adipocytes; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Brimonidine Tartrate; Calcium-Calmodulin-Dependent Protein Kinases; Cell Differentiation; Cell Division; Culture Media, Serum-Free; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Humans; Idazoxan; Kinetics; Lipolysis; Mice; Mutagenesis, Site-Directed; Phosphotyrosine; Quinoxalines; Receptors, Adrenergic, alpha-2; Recombinant Fusion Proteins; Sodium Chloride; Transfection

1997
Low-affinity conditions for agonists increase the binding of the antagonist [3H]RX821002 to the alpha(2B/C)-adrenoceptor subtypes in human brain and rat kidney.
    European journal of pharmacology, 1997, Jul-30, Volume: 332, Issue:1

    Topics: Adrenergic alpha-Antagonists; Animals; Brain; Brain Chemistry; Guanylyl Imidodiphosphate; Humans; Idazoxan; Kidney; Male; Membranes; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-2; Tritium

1997
Modulation of agonist binding to recombinant human alpha2-adrenoceptors by sodium ions.
    Biochimica et biophysica acta, 1998, Nov-19, Volume: 1448, Issue:1

    Topics: Adrenergic alpha-Agonists; Allosteric Regulation; Animals; Binding, Competitive; Cations, Monovalent; Guanylyl Imidodiphosphate; Humans; Idazoxan; Mammary Neoplasms, Animal; Mice; Norepinephrine; Receptors, Adrenergic, alpha-2; Recombinant Proteins; Sodium; Tumor Cells, Cultured

1998